We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 26 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  3. null/null
  4. 4 キャタレント・ジャパン Tokyo//Manufacturing and processing contract
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  3. Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 Pharmaceutical CDMO services 大塚化学

medicine Product List

196～210 item / All 516 items

Displayed results
【Research Material】World Market for the Treatment of Time Zone Shift Syndrome

【Research Material】World Market for the Treatment of Time Zone Shift Syndrome

World Market for Treatment of Time Zone Syndrome: Prescription Drugs, OTC, Hospital Pharmacies, Retail Pharmacies, Online

This research report (Global Time Zone Change Syndrome Treatment Market) investigates and analyzes the current status and outlook for the global market for treating time zone change syndrome over the next five years. It includes information on the overview of the global time zone change syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the time zone change syndrome treatment market focus on prescription drugs and OTC, while the segments by application target hospital pharmacies, retail pharmacies, and online. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for time zone change syndrome treatment. It also includes the market share of major companies in the time zone change syndrome treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Seasonal Influenza Vaccine Therapeutics

[Research Material] Global Market for Seasonal Influenza Vaccine Therapeutics

Global Market for Seasonal Influenza Vaccine Therapeutics: Children, Adolescents, Adults, Elderly, Hospitals, Clinics, Others

This research report (Global Seasonal Influenza Vaccines Therapeutics Market) investigates and analyzes the current status and outlook for the global market of seasonal influenza vaccine therapeutics over the next five years. It includes information on the overview of the global seasonal influenza vaccine therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include children, adolescents, adults, and the elderly, while the segments by application target hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of seasonal influenza vaccine therapeutics. It also includes the market share of major companies in seasonal influenza vaccine therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Small Molecule Targeted Therapy

[Research Material] The Global Market for Small Molecule Targeted Therapy

Global Market for Small Molecule Targeted Therapies: TKIs, Multi-Target Inhibitors, Others, Liver Cancer, Colorectal Cancer, Lung Cancer, Stomach Cancer, Breast Cancer, Esophageal Cancer ...

This research report (Global Small Molecule Targeted Therapy Market) investigates and analyzes the current status and outlook for the global small molecule targeted therapy market over the next five years. It includes information on the overview of the global small molecule targeted therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the small molecule targeted therapy market include TKI, multi-target inhibitors, and others, while the segments by application cover liver cancer, colorectal cancer, lung cancer, gastric cancer, breast cancer, esophageal cancer, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for small molecule targeted therapy. It also includes the market share of major companies in small molecule targeted therapy, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Amino Acid Metabolism Disorder Drugs

[Research Material] Global Market for Amino Acid Metabolism Disorder Drugs

World Market for Amino Acid Metabolism Disorder Drugs: Arginine, Folic Acid, Vitamin B6 & B12, Thiamine, Vitamin D, Betaine, Carboxymethylcysteine, ...

This research report (Global Amino Acid Metabolism Disorder Drug Market) investigates and analyzes the current status and outlook for the global market of amino acid metabolism disorder drugs over the next five years. It includes information on the overview of the global amino acid metabolism disorder drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include arginine, folic acid, vitamins B6 & B12, thiamine, vitamin D, betaine, carnitine, dihydrochloride sapropterin, and others, while the segments by application focus on phenylketonuria, maple syrup urine disease, argininosuccinic aciduria, citrullinemia, and homocystinuria. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for amino acid metabolism disorder drugs. The report also includes the market share of major companies in the amino acid metabolism disorder drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Cryptococcosis Treatment

[Research Material] Global Market for Cryptococcosis Treatment

Global Market for Cryptococcosis Treatment: Amphotericin B, Flucytosine, Fluconazole, Hospital Pharmacies, Retail Pharmacies, Drugstores, Others

This research report (Global Cryptococcosis Treatment Market) investigates and analyzes the current state and outlook for the global cryptococcosis treatment market over the next five years. It includes information on the overview of the global cryptococcosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the cryptococcosis treatment market focus on Amphotericin B, Flucytosine, and Fluconazole, while the segments by application target hospital pharmacies, retail pharmacies, drugstores, and others. The regional segments calculate the market size for cryptococcosis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in cryptococcosis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rare Neurological Disease Treatments

[Research Material] Global Market for Rare Neurological Disease Treatments

Global Market for Rare Neurological Disease Treatments: Biologics, Organic Compounds, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Rare Neurological Disease Treatment Market) investigates and analyzes the current state and outlook for the global market for rare neurological disease treatments over the next five years. It includes information on the overview of the global rare neurological disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rare neurological disease treatment market focus on biopharmaceuticals and organic compounds, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for rare neurological disease treatments by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the rare neurological disease treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Malignant Glioma Therapeutics

[Research Material] Global Market for Malignant Glioma Therapeutics

Global Market for Malignant Glioma Treatment Drugs: Alkylating Agents, VEGF/VEGFR Inhibitors, Anti-Angiogenesis Drugs, Hospitals, Cancer Research Institutions, Diagnostic Centers, Others

This research report (Global Malignant Glioma Drugs Market) investigates and analyzes the current state and outlook for the global market of malignant glioma treatment drugs over the next five years. It includes information on the overview of the global malignant glioma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include alkylating agents, VEGF/VEGFR inhibitors, and anti-angiogenic drugs, while the segments by application target hospitals, cancer research institutions, diagnostic centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for malignant glioma treatment drugs. It also includes the market share of major companies in the malignant glioma treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Morquio Syndrome Treatment

[Research Material] The Global Market for Morquio Syndrome Treatment

Global Market for Morquio Syndrome Treatment: Morquio A, Morquio B, Hospitals, Clinics, Others

This research report (Global Morquio Syndrome Treatment Market) investigates and analyzes the current state and future outlook of the global market for Morquio syndrome treatment over the next five years. It includes information on the overview of the global Morquio syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on Morquio A and Morquio B, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Morquio syndrome treatment. It also includes the market share of major companies in Morquio syndrome treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Terbinafine Hydrochloride Medication

[Research Material] Global Market for Terbinafine Hydrochloride Medication

World Market for Terbinafine Hydrochloride: Topical, Oral, Nail Infections, Toenail Infections, Others

This research report (Global Terbinafine Hydrochloride Drug Market) investigates and analyzes the current status and outlook for the global terbinafine hydrochloride drug market over the next five years. It includes information on the overview of the global terbinafine hydrochloride drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on topical and oral forms, while the segments by application target nail infections, toenail infections, and others. The regional segments calculate the market size of terbinafine hydrochloride drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the terbinafine hydrochloride drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Gene Therapy Medicine

[Research Material] The Global Market for Gene Therapy Medicine

World Market for Gene Therapy Medicine: Oral, Injection, Cancer, Monogenic, Infectious Diseases, Cardiovascular Diseases, Others

This research report (Global Gene Therapy Medicine Market) investigates and analyzes the current state and future outlook of the global gene therapy medicine market over the next five years. It includes information on the overview of the global gene therapy medicine market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on oral and injection methods, while the segments by application target cancer, monogenic diseases, infectious diseases, cardiovascular diseases, and others. The regional segments calculate the market size of gene therapy medicine by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gene therapy medicine, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

Head and neck cancer treatment drugs/treatment global market: PD inhibitors, microtubule inhibitors, EGFR inhibitors, surgery, radiation therapy, chemotherapy, immunotherapy.

This research report (Global Head and Neck Cancer Drugs/Therapeutics Market) investigates and analyzes the current status and outlook for the global market of head and neck cancer treatment drugs/therapeutics over the next five years. It includes information on the overview of the global head and neck cancer treatment drugs/therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the head and neck cancer treatment drugs/therapeutics market focus on PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application target surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments calculate the market size for head and neck cancer treatment drugs/therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the head and neck cancer treatment drugs/therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Amlodipine Besylate

[Research Material] Global Market for Amlodipine Besylate

World Market for Amlodipine Besylate: 2.5mg, 5mg, 10mg, Hypertension, Heart Disease

This research report (Global Amlodipine Besylate Market) investigates and analyzes the current state and outlook for the global market of amlodipine besylate over the next five years. It includes information on the overview of the global amlodipine besylate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the amlodipine besylate market focus on 2.5mg, 5mg, and 10mg, while the segments by application target hypertension and heart disease. The regional segments calculate the market size of amlodipine besylate by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the amlodipine besylate market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gout Treatment Drugs

[Research Material] Global Market for Gout Treatment Drugs

World Market for Gout Treatment Drugs: NSAIDs, Corticosteroids, Colchicine, Uric Acid Lowering Drugs, Acute Gout, Chronic Gout

This research report (Global Gout Therapeutics Market) investigates and analyzes the current status and outlook for the global market for gout therapeutics over the next five years. It includes information on the overview of the global gout therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include NSAIDs, corticosteroids, colchicine, and urate-lowering drugs, while the segments by application focus on acute gout and chronic gout. The regional segments calculate the market size for gout therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gout therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Fabry Disease Treatment

[Research Material] The Global Market for Fabry Disease Treatment

Global Market for Fabry Disease Treatment: Enzyme Replacement Therapy (ERT), Chaperone Therapy, Substrate Reduction Therapy (SRT), Others, Hospitals, Clinics, Others

This research report (Global Fabry Disease Treatment Market) investigates and analyzes the current status and outlook for the global Fabry disease treatment market over the next five years. It includes information on the overview of the global Fabry disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Fabry disease treatment market include enzyme replacement therapy (ERT), chaperone therapy, substrate reduction therapy (SRT), and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Fabry disease treatment. It also includes the market share of major companies in Fabry disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

World Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Cabomety...

This research report (Global Kidney Cancer and Renal Cell Carcinoma (RCC)) investigates and analyzes the current status and outlook for the global market of kidney cancer and renal cell carcinoma (RCC) treatment drugs over the next five years. It includes information on the overview of the global kidney cancer and renal cell carcinoma (RCC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Afinitor (everolimus), Avastin (bevacizumab), Cabometyx (cabozantinib), Inlyta (axitinib), Nexavar (sorafenib), Proleukin (aldesleukin), Torisel (temsirolimus), Sutent (sunitinib), and Votrient (pazopanib). The segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.